← Back to Search
Chemical Characterization Of Pyridoxalated Hemoglobin Polyoxyethylene Conjugate.
T. Talarico, K. J. Guise, C. J. Stacey
Published 2000 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) was developed in the 1980s as an oxygen carrier and is now under development for treatment of nitric oxide-dependent, volume refractory shock. PHP is made by derivatizing human stroma-free hemoglobin with pyridoxal-5-phosphate and polyoxyethylene (POE). A unique aspect of using POE for modification is that unlike its mono-methoxy polyethylene glycol (PEG) relatives, POE is bifunctional. The result of derivatization of stroma-free hemoglobin is a complex mixture of modified hemoglobin and other red cell proteins. The molecular weight profile, based on size exclusion chromatography, is bimodal and has a number average molecular weight of approximately 105¿ omitted¿000 and a weight average molecular weight of approximately 187¿ omitted¿000. The mixture of hemoglobin molecules has on average 3.3 pyridoxal and 5.0 polyoxyethylene units per tetramer. A portion of the tetramers are linked by POE crosslinks. The hemoglobin tetramers retain their ability to dissociate into dimer pairs and only a small percentage of the dimer pairs are not modified with POE. The SDS-PAGE profile exhibits the ladder-like appearance commonly associated with polyethylene glycol-modified proteins. The isoelectric focusing profile is broad, demonstrating a pI range of 5.0-6.5. The hydrodynamic size of PHP was determined to be approximately 7.2 nm by dynamic light scattering. Soluble red blood cell proteins, such as catalase, superoxide dismutase, and carbonic anhydrase, are present in PHP and are also modified by POE.
This paper references
Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface-conjugated.
K. Vandegriff (1997)
Preparation and properties of hemoglobin modified with derivatives of pyridoxal.
R. Benesch (1981)
Primary structure of a dimeric haemoglobin from the deep-sea cold-seep clam Calyptogena soyoae.
T. Suzuki (1989)
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution.
R. Przybelski (1996)
Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury.
S. Razack (1997)
Reaction of nitric oxide with heme proteins and model compounds of hemoglobin.
V. Sharma (1987)
Enzymatic protection from autoxidation for crosslinked hemoglobins.
T. Yang (1994)
Role of free radicals and catalytic metal ions in human disease: an overview.
B. Halliwell (1990)
Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase catalase.
F. D'Agnillo (1998)
Renal effects of multiple infusion of pyridoxalated-hemoglobin-polyoxyethylene conjugate (PHP) solution in dogs.
T. Takahashi (1993)
A clinical safety trial of stroma‐free hemoglobin
J. Savitsky (1978)
The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery.
S. Gould (1998)
Alternative oxygen carriers
J. Hess (1996)
A new resuscitation fluid "stabilized hemoglobin" preparation and characteristics.
Y. Iwashita (1988)
The Anodic Hemoglobin of Anguilla anguilla
A. Fago (1997)
Autoxidation of pyridoxalated hemoglobin polyoxyethylene conjugate.
T. Talarico (1998)
Three-point cross-linking: potential red cell substitutes from the reaction of trimesoyl tris(methyl phosphate) with hemoglobin.
R. Kluger (1992)
Blood substitutes: evolution and future applications.
M. Scott (1997)
Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol*
R. Clark (1996)
Biological variation of superoxide dismutase in erythrocytes and glutathione peroxidase in whole blood.
M. Covas (1997)
Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients.
G. Reah (1997)
The therapeutic value of poly(ethylene glycol)-modified proteins
M. Nucci (1991)
On-line characterization of polyethylene glycol-modified proteins
M. Kunitani (1991)
Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
Y. Yabe (1999)
Hemoglobin autoxidation at physiological concentrations.
A. Mansouri (1987)
Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity.
S. P. Monkarsh (1997)
Reduction of hydroxyl radical generation in a rat hindlimb model of ischemia-reperfusion injury using crosslinked hemoglobin-superoxide dismutase-catalase.
F. D'Agnillo (1997)
PREPARATION, PHYSICO-CHEMICAL AND PHARMACOKINETIC CHARACTERIZATION OF MONOMETHOXYPOLY(ETHYLENE GLYCOL)- DERIVATIZED SUPEROXIDE DISMUTASE
F. Veronese (1989)
HEMOGLOBIN AND MYOGLOBIN.
A. Rossi-Fanelli (1964)
Determination of Polyethylene Glycols 4000 and 6000 in Plasma Protein Preparations
B. Skoog (1979)
Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2).
R. Chatterjee (1986)
Effects of a Hemoglobin-Based Oxygen Carrier (HBOC-201) on Hemodynamics and Oxygen Transport in Patients Undergoing Preoperative Hemodilution for Elective Abdominal Aortic Surgery
S. Kasper (1996)
Pyridoxalated hemoglobin polyoxyethylene conjugate reverses hyperdynamic circulation in septic sheep.
H. Bone (1998)
Peroxynitrite-mediated heme oxidation and protein modification of native and chemically modified hemoglobins.
A. Alayash (1998)
Access to a syllabus of human hemoglobin variants (1996) via the World Wide Web.
R. Hardison (1998)
Synthesis and characterization of superoxide dismutase-deferoxamine conjugate via polyoxyethylene: a new molecular device for removal of a variety of reactive oxygen species.
H. Sato (1995)
Characterization of SDS--PAGE-separated proteins by matrix-assisted laser desorption/ionization mass spectrometry.
X. Liang (1996)
Analysis of polyethylene glycol modified superoxide dismutase by chromatographic, electrophoretic, light scattering, chemical and enzymatic methods.
P. Mcgoff (1988)
Detection of residual polyethylene glycol derivatives in pyridoxylated-hemoglobin-polyoxyethylene conjugate.
P. J. Miles (1997)
This paper is referenced by
Biochemistry, Physiology, and Complications of Blood Doping: Facts and Speculation
G. Lippi (2006)
Current Status and Future Directions
Toby A. Silverman (2009)
Stopped-flow fluorescence method for the detection of heme degradation products in solutions of chemically modified hemoglobins and peroxide.
Y. Jia (2002)
Chapter 39 – Surface Decoration of Hemoglobin with Polyethylene Glycol
S. Acharya (2006)
Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock.
C. Privalle (2000)
Characterization of Poly(ethylene glycol)-modified Bovine Hemoglobin By Capillary Zone Electrophoresis
Xian-Zhong Li (2007)
Oxygen Delivery by Allosteric Effectors of Hemoglobin, Blood Substitutes, and Plasma Expanders
B. Campanini (2003)
Bovine serum albumin-bovine hemoglobin conjugate as a candidate blood substitute
T. Hu (2004)
Toxicities of hemoglobin solutions: in search of in‐vitro and in‐vivo model systems
P. Buehler (2004)
Methodologies for detection of hemoglobin-based oxygen carriers.
C. Goebel (2005)
Evidence that rehydrated, lyophilized red blood cells are sufficiently deformable for normal microcirculation transit
T. H. Fischer (2004)
Hemoglobin-based Oxygen Carriers: Current Status and Future Directions
Toby A Silverman (2009)
Interactions of Hemoglobin with Vesicles and Tubes Formed from Mixtures of Histidine-Derived Bolaamphiphile and Conventional Surfactants
Y. Chen (2011)
Proof of homologous blood transfusion through quantification of blood group antigens.
M. Nelson (2003)
O‐raffinose crosslinked hemoglobin lacks site‐specific chemistry in the central cavity: Structural and functional consequences of β93Cys modification
R. Boykins (2005)
IN-VITRO AND ANIMAL MODELS FOR EVALUATING HBOC SOLUTIONSBUEHLER AND ALAYASH
P. Buehler (2004)
Hemoglobin‐based oxygen carriers: current status and future directions
Toby A Silverman (2009)
Synthesis and characterization of hemoglobin conjugates with antioxidant enzymes via poly(ethylene glycol) cross-linker (Hb-SOD-CAT) for protection from free radical stress.
Venkatareddy Nadithe (2010)
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: confirmation by size-exclusion HPLC.
E. Varlet-Marie (2004)
Cellulose-acetate electrophoresis reveals haemoglobin variation in Iranian domestic shorthaired cats
A. Araghi (2014)
OXIDATIVE MECHANISMS OF HEMOGLOBIN-BASED BLOOD SUBSTITUTES*
A. Alayash (2001)
Engineering hemoglobin to enable homogenous PEGylation without modifying protein functionality.
C. Cooper (2020)
Construction of manganese porphyrin modified hemoglobin complex and its antioxidant activities
Hidenori Murata (2008)
Haemoglobin-based oxygen carriers and myocardial infarction
T. Estep (2019)
Application of high‐precision isotope ratio monitoring mass spectrometry to identify the biosynthetic origins of proteins
I. Apostoł (2001)
Doping with Artificial Oxygen Carriers
Y. Schumacher (2004)
Comparative studies of interactions of hemoglobin with single-chain and with gemini surfactants.
Y. Wang (2009)